Utah Medical Products (NASDAQ:UTMD) Stock Crosses Above 200-Day Moving Average – Time to Sell?

Utah Medical Products, Inc. (NASDAQ:UTMD)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $65.75 and traded as high as $72.04. Utah Medical Products shares last traded at $69.57, with a volume of 29,634 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “hold (c-)” rating on shares of Utah Medical Products in a research report on Friday, May 22nd. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, Utah Medical Products currently has a consensus rating of “Hold”.

Utah Medical Products Price Performance

The company has a 50 day simple moving average of $68.46 and a 200-day simple moving average of $65.79. The firm has a market cap of $224.25 million, a PE ratio of 21.50 and a beta of 0.36.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 EPS for the quarter. The firm had revenue of $8.53 million for the quarter. Utah Medical Products had a net margin of 29.04% and a return on equity of 8.79%.

Utah Medical Products Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, July 3rd. Investors of record on Wednesday, June 17th were given a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date was Wednesday, June 17th. Utah Medical Products’s dividend payout ratio (DPR) is presently 37.80%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Jane Street Group LLC purchased a new position in shares of Utah Medical Products in the first quarter worth about $317,000. Geode Capital Management LLC grew its position in Utah Medical Products by 6.5% during the 2nd quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock worth $6,537,000 after acquiring an additional 7,040 shares during the last quarter. Rhumbline Advisers increased its stake in Utah Medical Products by 10.6% in the 2nd quarter. Rhumbline Advisers now owns 5,716 shares of the medical instruments supplier’s stock worth $325,000 after purchasing an additional 550 shares during the period. Russell Investments Group Ltd. increased its stake in Utah Medical Products by 550.5% in the 2nd quarter. Russell Investments Group Ltd. now owns 2,758 shares of the medical instruments supplier’s stock worth $157,000 after purchasing an additional 2,334 shares during the period. Finally, Invesco Ltd. lifted its position in Utah Medical Products by 33.8% in the second quarter. Invesco Ltd. now owns 4,955 shares of the medical instruments supplier’s stock valued at $282,000 after purchasing an additional 1,253 shares during the last quarter. 69.60% of the stock is owned by institutional investors.

About Utah Medical Products

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single?use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non?invasive monitoring products used in acute and long?term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end?tidal carbon dioxide (CO?).